PatientWing Insights
Expert perspectives, research updates, and innovative solutions driving the future of patient recruitment and clinical trials.
Single-channel recruitment misses most eligible patients. See how PatientWing combines digital ads, advocacy partnerships, community outreach, and multilingual support to reach patients where they are and keep them engaged.
July 1, 2026
PatientWing is making waves at SCOPE Summit 2024! As a sponsor and finalist for the Participant Engagement Award, we're set to take center stage at Booth 1113. Dive into groundbreaking advancements in participant recruitment and enrollment, explore our award-worthy journey, and connect with us at this exciting event!
The FDA issued a draft guidance in 2022, urging industry sponsors to develop a Race and Ethnicity Diversity Plan for clinical trial participation, focusing on underrepresented groups. The guidance, while not legally binding, reflects an industry shift towards diverse patient recruitment, with specific requirements for data collection and enrollment strategies for diverse participants.
Compliance with evolving consumer and patient privacy regulations has increased the burden on biopharmaceutical companies running clinical trials. Learn how to meet these requirements through technological, procedural, legal, data storage, and data transfer considerations.